Nutraceuticals, aging, and cognitive dysfunction - 22/08/11
Doi : 10.1016/j.cvsm.2003.09.007
Elizabeth Head, PhD a, ⁎ 
, Steven C Zicker, PhD, DVM, b
, Steven C Zicker, PhD, DVM, b a Institute for Brain Aging and Dementia, University of California at Irvine, 1259 Gillespie NRF, Irvine, CA 92697-4540, USA
b Science and Technology Center, Hill's Pet Nutrition, Inc., P.O. Box 1658, Topeka, KS 66601-1658, USA
Corresponding author.Plan
 | These authors have indicated that they have a relationship that, in the context of the subject of their presentation, could be perceived as an apparent conflict of interest. This pertains to relationships with food companies, pharmaceutical companies, or other corporations whose products or services are related to the subject matter of the presentation topic. The authors want it to be known that this article was written with integrity and that any perceived conflict of interest did not affect their research, information, or topic as described in this text. This work was supported by Grant No. AG12694 from the National Institutes of Aging, U.S. Department of the Army, Contract No. DAMD17-98-1-8622. The content of the information does not necessarily reflect the position or the policy of the government, and no official endorsement should be inferred. Hill's Pet Nutrition, Topeka, KS, provided additional funding. |
© 2004
Elsevier Inc. Tous droits réservés.
Vol 34 - N° 1
P. 217-228 - janvier 2004 Retour au numéro
Article précédent
- Traditional and nontraditional effective and noneffective therapies for cardiac disease in dogs and cats
- Paul D Pion
- Modulation of immune response through nutraceutical interventions: implications for canine and feline health
- Michael G Hayek, Stefan P Massimino, Michael A Ceddia
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?